RU2002107449A - Хемосенсибилизатор - Google Patents
Хемосенсибилизатор Download PDFInfo
- Publication number
- RU2002107449A RU2002107449A RU2002107449/14A RU2002107449A RU2002107449A RU 2002107449 A RU2002107449 A RU 2002107449A RU 2002107449/14 A RU2002107449/14 A RU 2002107449/14A RU 2002107449 A RU2002107449 A RU 2002107449A RU 2002107449 A RU2002107449 A RU 2002107449A
- Authority
- RU
- Russia
- Prior art keywords
- chemosensitizer
- antimetabolites
- chemotherapeutic agent
- chemotherapeutic agents
- agent according
- Prior art date
Links
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims 4
- 239000002246 antineoplastic agent Substances 0.000 claims 4
- 229940127089 cytotoxic agent Drugs 0.000 claims 4
- 230000003034 chemosensitisation Effects 0.000 claims 3
- 239000006114 chemosensitizer Substances 0.000 claims 3
- 230000000340 anti-metabolite Effects 0.000 claims 2
- 229940100197 antimetabolite Drugs 0.000 claims 2
- 239000002256 antimetabolite Substances 0.000 claims 2
- -1 dunorubicin Chemical compound 0.000 claims 2
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 claims 1
- FTNJQNQLEGKTGD-UHFFFAOYSA-N 1,3-benzodioxole Chemical class C1=CC=C2OCOC2=C1 FTNJQNQLEGKTGD-UHFFFAOYSA-N 0.000 claims 1
- 108010006654 Bleomycin Proteins 0.000 claims 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 1
- 229930012538 Paclitaxel Natural products 0.000 claims 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 claims 1
- 229940009456 adriamycin Drugs 0.000 claims 1
- 229960001561 bleomycin Drugs 0.000 claims 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 claims 1
- 229960004562 carboplatin Drugs 0.000 claims 1
- 190000008236 carboplatin Chemical compound 0.000 claims 1
- 229960003677 chloroquine Drugs 0.000 claims 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 claims 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims 1
- 229960004316 cisplatin Drugs 0.000 claims 1
- 229960004679 doxorubicin Drugs 0.000 claims 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 claims 1
- 229960005420 etoposide Drugs 0.000 claims 1
- 229960002949 fluorouracil Drugs 0.000 claims 1
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 claims 1
- 229960001156 mitoxantrone Drugs 0.000 claims 1
- 229960001592 paclitaxel Drugs 0.000 claims 1
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 claims 1
- 229940075559 piperine Drugs 0.000 claims 1
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 claims 1
- 235000019100 piperine Nutrition 0.000 claims 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 claims 1
- 229960001225 rifampicin Drugs 0.000 claims 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 1
- 229960000303 topotecan Drugs 0.000 claims 1
- UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 claims 1
- 229960003048 vinblastine Drugs 0.000 claims 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 claims 1
- 229960004528 vincristine Drugs 0.000 claims 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 claims 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (7)
1. R-1-3 бензодиоксолы в качестве хемосенсибилизатора со структурной формулой
2. Хемосенсибилизатором по п.1 может быть пиперин, в котором R представляет собой
3. Хемосенсибилизатор по пп.1 и 2, полезный при преодолении устойчивости к хемотерапевтическим агентам.
4. Хемотерапевтический агент по п.3 может быть рифампицином.
5. Хемотерапевтические агенты по п.3 могут быть антиметаболитами.
6. Антиметаболиты по п.5 могут выбираться из группы, содержащей доксорубицин, доунорубицин, винкристин, винбластин, паклитаксель, кар-боплатин, этопозид, таксотрен, топотекан, адриамицин, цисплатин, 5-фторурацил, митоксантрон, блеомицин и тому подобные.
7. Хемотерапевтический агент по п.3 может быть хлорохином.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN591/MUM/2000 | 2000-06-26 | ||
| IN591MU2000 | 2000-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2002107449A true RU2002107449A (ru) | 2003-11-20 |
Family
ID=11097259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2002107449/14A RU2002107449A (ru) | 2000-06-26 | 2001-06-26 | Хемосенсибилизатор |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1296682A4 (ru) |
| AP (1) | AP2002002453A0 (ru) |
| AU (1) | AU7440301A (ru) |
| EA (1) | EA005672B1 (ru) |
| RU (1) | RU2002107449A (ru) |
| WO (1) | WO2002000164A2 (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003223111A1 (en) * | 2003-03-31 | 2004-10-25 | Council Of Scientific And Industrial Research | Use of cuminum cyminum extract and piperine for potentiation of bioefficacy of anti infectives |
| US8580752B2 (en) * | 2005-03-31 | 2013-11-12 | Council Of Scientitic And Industrial Research | Aromatic amides as potentiators of bioefficacy of anti-infective drugs |
| JP5590882B2 (ja) | 2006-06-26 | 2014-09-17 | ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア | 化学療法増感剤としてのシステインに富む酸性分泌タンパク質（ｓｐａｒｃ） |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0650728B1 (en) * | 1993-10-29 | 2002-02-27 | Council of Scientific and Industrial Research | Pharmaceutical compositions containing piperine and an antituberculosis or antileprosydrug |
| IN176897B (ru) * | 1993-10-29 | 1996-09-28 | Cadila Lab Ltd | |
| US5744161A (en) * | 1995-02-24 | 1998-04-28 | Sabinsa Corporation | Use of piperine as a bioavailability enhancer |
| EP0935964A1 (en) * | 1998-02-12 | 1999-08-18 | Panacea Biotec Limited | Pharmaceutical compositions containing NSAIDs and piperine |
-
2001
- 2001-06-26 EA EA200200288A patent/EA005672B1/ru not_active IP Right Cessation
- 2001-06-26 WO PCT/IB2001/001133 patent/WO2002000164A2/en not_active Ceased
- 2001-06-26 EP EP01940915A patent/EP1296682A4/en not_active Withdrawn
- 2001-06-26 RU RU2002107449/14A patent/RU2002107449A/ru not_active Application Discontinuation
- 2001-06-26 AU AU74403/01A patent/AU7440301A/en not_active Abandoned
- 2001-06-26 AP APAP/P/2002/002453A patent/AP2002002453A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1296682A2 (en) | 2003-04-02 |
| WO2002000164A2 (en) | 2002-01-03 |
| WO2002000164A3 (en) | 2002-10-24 |
| EP1296682A4 (en) | 2004-11-10 |
| EA005672B1 (ru) | 2005-04-28 |
| AU7440301A (en) | 2002-01-08 |
| WO2002000164A8 (en) | 2002-05-16 |
| AP2002002453A0 (en) | 2002-06-30 |
| EA200200288A1 (ru) | 2003-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2404689A1 (en) | Multi-compartment pouch comprising separate solid and liquid components | |
| EP2433655A3 (en) | Homoarginine-prodrugs of amphetamine | |
| EP2253330A3 (en) | Conjugated biological molecules and their preparation | |
| TW200631941A (en) | The organic compounds, electric charges transmission material and the organic electric field emit elements | |
| JP2002212195A5 (ru) | ||
| PT1741774E (pt) | Composições para máquinas de lavar loiça e sua utilização | |
| WO2003011173A3 (en) | Bioabsorbable adhesive compunds and compositions | |
| CA2434091A1 (en) | Radiation detector comprising a hybrid perovskite scintillator | |
| JP2007537301A5 (ru) | ||
| CA2699462A1 (en) | Noncrystalline composite alkali metal titanate composition and friction material | |
| EP1975164A3 (en) | Octahydrobenzimidazolone compounds as analgetics | |
| DE60125654D1 (de) | Mesomorphe Verbindung, polymere mesomorphe Verbindung, und Elektrolyt und sekundäre Batterie, die diesen enthält | |
| RU2002107449A (ru) | Хемосенсибилизатор | |
| ATE548488T1 (de) | Fasern und flächengebilde hergestellt aus schlagfesten propylencopolymeren | |
| DE60117567D1 (de) | Modifzierte polyamide, ihre zusammensetzungen und macromolekulare verbindungen zu ihrer herstellung | |
| WO2002048143A3 (en) | Antimicrobial 2-pyridones, their compositions and uses | |
| CA2421008A1 (en) | Substituted heterocyclic compounds for treating multidrug resistance | |
| JP2004517948A5 (ru) | ||
| DE50104919D1 (de) | Ternäre Pigment-Zusammensetzungen | |
| JP2007516980A5 (ru) | ||
| WO2017123308A3 (en) | Superalloy compositions including at least one ternary intermetallic compound and applications thereof | |
| CA2420999A1 (en) | 2-substituted heterocyclic compounds and their use in treating multidrug resistance | |
| EP1958634A3 (en) | Substituted piperidines as inhibitors of beta-secretase, cathepsin D, plasmepsin II and/or HIV protease | |
| FR2866891B1 (fr) | Compositions thermoplastiques de copolymeres d'ethylene greffes par des motifs polyethers | |
| WO2004096147A3 (en) | Oxo-pyrimidine compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA94 | Acknowledgement of application withdrawn (non-payment of fees) |
Effective date: 20051014 |